These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20839171)

  • 41. Depression and endocrine disorders: focus on the thyroid and adrenal system.
    Musselman DL; Nemeroff CB
    Br J Psychiatry Suppl; 1996 Jun; (30):123-8. PubMed ID: 8864158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type-D personality, depression, and cardiac prognosis: cortisol dysregulation as a mediating mechanism.
    Denollet J; Kupper N
    J Psychosom Res; 2007 Jun; 62(6):607-9. PubMed ID: 17540217
    [No Abstract]   [Full Text] [Related]  

  • 43. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
    Schüle C; Zill P; Baghai TC; Eser D; Zwanzger P; Wenig N; Rupprecht R; Bondy B
    Psychoneuroendocrinology; 2006 Sep; 31(8):1019-25. PubMed ID: 16890377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NIDDK international conference report on diabetes and depression: current understanding and future directions.
    Holt RI; de Groot M; Lucki I; Hunter CM; Sartorius N; Golden SH
    Diabetes Care; 2014 Aug; 37(8):2067-77. PubMed ID: 25061135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Neurobiological basis of depressive disorders].
    Stoppel C; Bielau H; Bogerts B; Northoff G
    Fortschr Neurol Psychiatr; 2006 Dec; 74(12):696-705. PubMed ID: 17167728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New approaches to antidepressant drug discovery: beyond monoamines.
    Berton O; Nestler EJ
    Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Research progress on therapeutic mechanism of depression treated by traditional chinese medicine].
    Mao QQ; Huang Z
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(10):877-80. PubMed ID: 17655134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Not fade away: the HPA axis and depression.
    Cowen PJ
    Psychol Med; 2010 Jan; 40(1):1-4. PubMed ID: 19335939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maternal and environmental factors influence the hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone infusion in offspring of mothers with or without mood disorders.
    Ronsaville DS; Municchi G; Laney C; Cizza G; Meyer SE; Haim A; Radke-Yarrow M; Chrousos G; Gold PW; Martinez PE
    Dev Psychopathol; 2006; 18(1):173-94. PubMed ID: 16478558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY; Lowy MT; Koenig JI
    Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
    [No Abstract]   [Full Text] [Related]  

  • 51. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB.
    Xu Y; Ku B; Tie L; Yao H; Jiang W; Ma X; Li X
    Brain Res; 2006 Nov; 1122(1):56-64. PubMed ID: 17022948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renin-angiotensin-aldosterone system, HPA-axis and sleep-EEG changes in unmedicated patients with depression after total sleep deprivation.
    Murck H; Uhr M; Ziegenbein M; Künzel H; Held K; Antonijevic IA; Schüssler P; Steiger A
    Pharmacopsychiatry; 2006 Jan; 39(1):23-9. PubMed ID: 16453251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior.
    Matrisciano F; Modafferi AM; Togna GI; Barone Y; Pinna G; Nicoletti F; Scaccianoce S
    Neuropharmacology; 2010 Jun; 58(7):1078-84. PubMed ID: 20138062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neurobiological views on endogenous causes of mental diseases: Influence of environment around fetal and neonatal stage on brain morphogenesis--predisposition for depressive disorders].
    Watanabe Y
    Seishin Shinkeigaku Zasshi; 2000; 102(3):272-80. PubMed ID: 10810915
    [No Abstract]   [Full Text] [Related]  

  • 55. Evolving model of depression as an expression of multiple interacting risk factors.
    O'Keane V
    Br J Psychiatry; 2000 Dec; 177():482-3. PubMed ID: 11102319
    [No Abstract]   [Full Text] [Related]  

  • 56. [The relation between thyroid function and depression: a review].
    Bahls SC; de Carvalho GA
    Braz J Psychiatry; 2004 Mar; 26(1):41-9. PubMed ID: 15057840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Association of diabetes type 2 and depression - behavioural and biological aspects].
    Wagner G; Icks A; Redaelli M; Albers B; Abholz HH
    Dtsch Med Wochenschr; 2014 Feb; 139(8):369-74. PubMed ID: 24519113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic syndrome--from the neurotrophic hypothesis to a theory.
    Hristova MG
    Med Hypotheses; 2013 Oct; 81(4):627-34. PubMed ID: 23899630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New insights into the pathogenesis and pathophysiology of depression].
    Schüle C; Baghai TC; Rupprecht R
    Nervenarzt; 2007 Nov; 78 Suppl 3():531-47; quiz 548-9. PubMed ID: 17960353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurobiological mechanisms in major depressive disorder.
    aan het Rot M; Mathew SJ; Charney DS
    CMAJ; 2009 Feb; 180(3):305-13. PubMed ID: 19188629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.